Factor XIII Val34Leu polymorphism does not affect the risk for thrombotic complications in patients with antiphospholipid syndrome.


Diz-Kucukkaya R., Hancer V., Inanc M., Nalcaci M., Pekcelen Y.

45th Annual Meeting of the American-Society-of-Hematology, SAN DIEGO, CALIFORNIA, 6 - 09 December 2003, vol.102, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Volume: 102
  • City: SAN DIEGO
  • Country: CALIFORNIA
  • Istanbul University Affiliated: Yes